145 related articles for article (PubMed ID: 4562175)
1. Immunosuppression and malignancy.
Br Med J; 1972 Sep; 3(5829):713-4. PubMed ID: 4562175
[No Abstract] [Full Text] [Related]
2. Malignancy and immunosuppression.
Kinlen LJ
Proc R Soc Med; 1972 Mar; 65(3):242. PubMed ID: 4563298
[No Abstract] [Full Text] [Related]
3. Another look at immunologic surveillance.
Schwartz RS
N Engl J Med; 1975 Jul; 293(4):181-4. PubMed ID: 1094290
[No Abstract] [Full Text] [Related]
4. Cancer and survival after cadaveric donor renal transplantation.
Sheil AG; Mahoney JF; Horvath JS; Johnson JR; Tiller DJ; May J; Stewart JH
Transplant Proc; 1979 Mar; 11(1):1052-4. PubMed ID: 377609
[No Abstract] [Full Text] [Related]
5. [Lymphomata in patients with kidney transplantation].
Robinson E; Better O
Harefuah; 1972 May; 82(10):474-5. PubMed ID: 4564550
[No Abstract] [Full Text] [Related]
6. A hematologist's appraisal of the problem cerebral lymphomas in transplanted patients. A speculative review.
Marmont AM
Haematologica; 1974 Dec; 59(4):489-98. PubMed ID: 4219006
[No Abstract] [Full Text] [Related]
7. Tumour development following immunosuppression.
Allison AC
Proc R Soc Med; 1970 Oct; 63(10):1077-80. PubMed ID: 4320709
[No Abstract] [Full Text] [Related]
8. Tumor incidence in human allograft recipients.
Penn I
Transplant Proc; 1979 Mar; 11(1):1047-51. PubMed ID: 377608
[No Abstract] [Full Text] [Related]
9. [Malignant tumors under immunosuppression, a new problem in transplant-recipients].
Enderlin F; Guisan Y
Helv Chir Acta; 1973 Dec; 40(5):773-6. PubMed ID: 4589045
[No Abstract] [Full Text] [Related]
10. De novo malignancy following liver transplantation: a single-center study.
Levy M; Backman L; Husberg B; Goldstein R; McMillan R; Gibbs J; Gonwa TA; Holman M; Klintmalm G
Transplant Proc; 1993 Feb; 25(1 Pt 2):1397-9. PubMed ID: 8442153
[No Abstract] [Full Text] [Related]
11. [A case of malignant lymphoma after renal transplantation].
Oyama H; Yamao K; Sugiyama T; Matsuura O; Murakami S; Ikeda K; Inoue S
No Shinkei Geka; 1997 Jul; 25(7):655-60. PubMed ID: 9218261
[TBL] [Abstract][Full Text] [Related]
12. [Pathogenesis of lymphoreticular neoplasms in transplant recipients].
Krüger G
Verh Dtsch Ges Pathol; 1970; 54():175-81. PubMed ID: 4104526
[No Abstract] [Full Text] [Related]
13. Predictive oncology. 3.
Bierman HR
Int Surg; 1973; 58(11):768-73. PubMed ID: 4584400
[No Abstract] [Full Text] [Related]
14. Increasing transplant cancer patient survival by conversion of immunosuppressive agents.
Chuang FR; Hsieh H; Hsu KT; Huang HF
Transplant Proc; 1996 Jun; 28(3):1346-7. PubMed ID: 8658687
[No Abstract] [Full Text] [Related]
15. [Tumors and kidney transplantation].
Brünisholz M; Hodel K; Brunner FP; Harder F; Torhorst J; Thiel G
Schweiz Med Wochenschr; 1984 Dec; 114(51):1915-24. PubMed ID: 6395328
[TBL] [Abstract][Full Text] [Related]
16. Cancers after cyclosporine therapy.
Penn I; Brunson ME
Transplant Proc; 1988 Jun; 20(3 Suppl 3):885-92. PubMed ID: 3388524
[No Abstract] [Full Text] [Related]
17. [Carcinogenesis and immunosuppression].
Schmähl D
Dtsch Med Wochenschr; 1971 Nov; 96(45):1771-2. PubMed ID: 4942320
[No Abstract] [Full Text] [Related]
18. Assessment of the risks of malignancy and lymphomas developing in patients using Sandimmune.
Cockburn I
Transplant Proc; 1987 Feb; 19(1 Pt 2):1804-7. PubMed ID: 3547886
[No Abstract] [Full Text] [Related]
19. Influence of antilymphocyte globulin upon the incidence of malignancies after kidney transplantation.
Luciani J; Benalia H; Bitker MO; Mouquet C; Chartier-Kastler E; Ourhama S; Jacobs C; Chatelain C; Viars P
Transplant Proc; 1993 Jun; 25(3):2302. PubMed ID: 8516907
[No Abstract] [Full Text] [Related]
20. [Malignant neoplasms after organ transplantation].
Mol'kov IuN; Golikova SD; Balakirev EM
Vopr Onkol; 1980; 26(11):107-13. PubMed ID: 7006209
[No Abstract] [Full Text] [Related]
[Next] [New Search]
